Healthcare Experts Debate New Methods of Assessing the Value of Prescription Drugs, Medical Devices, and Procedures

Published Jun 18, 2019

Value in Health Supplement Reports Findings of Third Annual ISPOR Summit

Lawrenceville, NJ, USA—June 18, 2019—Value in Health, the official journal of ISPOR, the professional society for health economics and outcomes research, announced today the publication of a new supplement, “New Approaches to Value Assessment: Towards More Informed Pricing in Healthcare.” The 6 articles included in this supplement are based on presentations from the Third Annual ISPOR Summit held in Washington, DC, USA on October 19, 2018. Full text of the articles is freely available online and the supplement will be indexed in MEDLINE®/PubMed. The supplement, which was published in June 2019 along with the regular issue of Value in Health, extends the reach and expands access to important discussions about how healthcare stakeholders in the United States are assessing value in healthcare today and into the future.

In his introductory editorial, ISPOR’s Chief Science Officer Richard J. Willke, PhD describes the ongoing challenges of value assessment, provides a concise background of the Society’s recent initiatives on value assessment frameworks, and briefly summarizes the presentations that inform the articles:

  1. Current Policy and Practice for Value-Based Pricing. Speaker: Mark B. McClellan, MD, PhD (Moderator: Federico Augustovski, MD, MSc, PhD)
  2. Current Value Frameworks—What’s New? Panelists: Richard H. Chapman, MS, PhD, Joshua J. Seidman, MHS, PhD, Lowell E. Schnipper, MD, Patrick P. Gleason, PharmD (Moderator: Richard J. Willke, PhD)
  3. Novel Approaches to Value Assessment Within the Cost-Effectiveness Framework. Panelists: Jeroen P. Jansen, PhD, Nancy J. Devlin, PhD, Susan Griffin, PhD (Moderator: Louis P. Garrison Jr, PhD)
  4. Novel Approaches to Value Assessment Beyond the Cost-Effectiveness Framework. Panelists: Robert W. Dubois, MD, PhD, F. Reed Johnson, PhD, J. Jaime Caro, MDCM, Charles E. Phelps, PhD (Moderator: Shelby D. Reed, RPh, PhD)
  5. Specific Value Assessment Considerations. Panelists: Adrian Towse, MA, Liz Spurgin, MBA, Patricia M. Danzon, PhD (Moderator: Sachin Kamal-Bahl, PhD)
  6. Practical Next Steps in Improving Value Measurement and Use. Panelists: Sachin Kamal-Bahl, PhD, Patrick P. Gleason, PharmD, Suzanne Schrandt, JD, Newell McElwee, PharmD, MSPH (Moderator: Daniel A. Ollendorf, PhD)

The ISPOR Summit, “New Approaches to Value Assessment: Towards More Informed Pricing in Healthcare,” was convened to expand on the work of ISPOR’s Special Task Force on US Value Assessment Frameworks and its research agenda, as well as work from other related initiatives. The event provided a forum for researchers, regulators, payers, and other stakeholders to examine the current state of healthcare value assessment and its role in pricing and coverage decisions.

“Topics presented during this summit may have limited effects on practices today or in the short-term; improving how we measure value and make decisions is intrinsically a long-term effort,” said Dr Willke. “Nevertheless, I hope that some of the ideas presented at the summit and in this supplement will resonate with you, sparking experimentation and leading to long-term improvements to value assessment frameworks. Advances here are crucial for both today’s and tomorrow’s patients.”

ISPOR acknowledges and thanks the sponsors of this supplement: Evidera, the National Pharmaceutical Council, and the PhRMA Foundation.

###

ABOUT ISPOR
ISPOR, the professional society for health economics and outcomes research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.
Web: www.ispor.org | LinkedIn: www.linkedin.com/company/ispororg | Twitter: www.twitter.com/ispororg (@ISPORorg) | YouTube: www.youtube.com/ispororg | Facebook: www.facebook.com/ispororg | Instagram: www.instagram.com/ispororg

ABOUT VALUE IN HEALTH
Value in Health (ISSN 1098-3015) is an international, indexed journal that publishes original research and health policy articles that advance the field of health economics and outcomes research to help healthcare leaders make evidence-based decisions. The journal’s 2017 impact factor score is 5.494. Value in Health is ranked 3rd among 94 journals in healthcare sciences and services, 3rd among 79 journals in health policy and services, and 6th among 353 journals in economics. Value in Health is a monthly publication that circulates to more than 10,000 readers around the world.
Web: www.ispor.org/valueinhealth | Twitter: www.twitter.com/isporjournals (@ISPORjournals)

Related Stories

ISPOR Global Panel Proposes New Structure to Improve Definitions of Digital Health Interventions

Apr 9, 2024

ISPOR—The Professional Society for Health Economics and Outcomes Research announced today the publication of a report from the ISPOR Digital Health Special Interest Group that proposes a new framework to help standardize and clarify definitions used for digital health interventions. The report, “The PICOTS-ComTeC Framework for Defining Digital Health Interventions: An ISPOR Special Interest Group Report” was published in the April 2024 issue of Value in Health.

ISPOR International Panel Calls for Consensus on Medication Adherence Measures

Feb 26, 2024

ISPOR—The Professional Society for Health Economics and Outcomes Research announced the publication of a new report from the ISPOR Medication Adherence and Persistence Special Interest Group revealing significant inconsistencies in how researchers measure the effectiveness of interventions aimed at improving medication adherence. The report, “A Systematic Review of Outcomes for Assessment of Medication Adherence Enhancing Interventions: An ISPOR Special Interest Group Report” was published in the February 2024 issue of Value in Health.

Global Experts Highlight Concerns With Implementation of IRA-Mandated Medicare Drug Price Negotiation Program

Dec 5, 2023

Value in Health announced the publication of 2 new commentaries by leading experts in health economics and outcomes research, both of which raise important questions as the Centers for Medicare & Medicaid Services move forward to implement the Inflation Reduction Act’s Medicare Drug Price Negotiation Program.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×